Astec LifeSciences share news and announcements
NSE: ASTECBSE: 533138Fertilizers & AgrochemicalsSmall Cap
Last close ₹663.70down ₹5.50 (0.82%)BSE ₹664.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹669.20.
52-week range of traded prices to 23 Oct 2026
₹513.40Low, 23 Mar 2026₹941.75High, 26 Nov 2025
- Next results date: the board meets on 26 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,479 Cr1,284th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Apr 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 31 Jul 2026
- −21.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 31 Jul 2026
- −4.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Apr 2026
- 1.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 33,48432.9% delivered
Astec LifeSciences dividends
25 filed, newest first.
May 2023
May 2022
Apr 2021
30 Apr · Dividend
May 2020
5 May · Dividend
May 2019
Apr 2019
30 Apr · Dividend
May 2018
2 May · Dividend
May 2017
May 2015
16 May · Dividend
Board of Directors of the Company at its meeting held on May 16, 2015, has recommend enhanced dividend of Rs.1.25/- per share (i.e. 12.50% on the face value of Rs 10/- each) for the period ended March 31, 2015 for the approval of the Shareholders at the ensuing Annual General Meeting as compared to Re 1/- per share (i.e.10% on the face value of Rs 10/- each) which was declared for the previous year.
Jun 2014
2 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2014,has recommend enhanced dividend of Rupee One per share (i.e. 10% on the face value of Rs. 10/- each) for the period ended March 31, 2014, for the approval of shareholders at the ensuing Annual General Meeting as compared to Seventy Five Paise per share (i.e. 7.5% on the face value of Rs. 10/- each) which was declared for the previous year.
May 2013
27 May · Dividend
Board of Directors of the Company at its meeting held on May 24, 2013 has Recommended a dividend of Seventy Five paise per share (i.e. 7.5% on face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.
May 2012
29 May · Dividend
Board of Director of the Company at its meeting held on May 28, 2012 has recommended a dividend of fifty paise per share (i.e. 5% on the face value of Rs.10/- each) for the approval of the shareholders at the ensuing Annual General Meeting.
May 2011
30 May · Dividend
Board of Directors of the Company at its meeting held on May 27, 2011 have recommended a dividend of 50 paisey per share (i.e. 5% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.
May 2010
24 May · Dividend
Board of Directors at its Meeting held on May 24, 2010 have recommended a dividend of Re. 1 per share (i.e. 10% on the face value of Rs. 10/- each) for the approval of the Shareholders at the ensuing Annual General Meeting.